Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 14.88
(0.4%)
CNY 14.88
(0.4%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 CNY | -119.35% |
| 2022 | 0.31 CNY | -53.73% |
| 2021 | 0.67 CNY | -28.72% |
| 2020 | 0.94 CNY | 8.05% |
| 2019 | 0.87 CNY | 7.41% |
| 2018 | 0.81 CNY | -7.95% |
| 2017 | 0.88 CNY | 18.92% |
| 2016 | 0.74 CNY | 60.87% |
| 2015 | 0.46 CNY | -13.21% |
| 2014 | 0.53 CNY | -3.64% |
| 2013 | 0.55 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.07 CNY | -142.0% |
| 2024 Q3 | 0.21 CNY | 394.12% |
| 2024 Q1 | 0.17 CNY | 126.98% |
| 2023 Q2 | 0.26 CNY | 36.84% |
| 2023 Q1 | 0.19 CNY | 155.88% |
| 2023 FY | - CNY | -119.35% |
| 2023 Q4 | -0.63 CNY | -2026.61% |
| 2023 Q3 | 0.03 CNY | -87.42% |
| 2022 Q4 | -0.34 CNY | -230.77% |
| 2022 Q3 | 0.26 CNY | 8.33% |
| 2022 Q2 | 0.24 CNY | -14.29% |
| 2022 Q1 | 0.28 CNY | 952.63% |
| 2022 FY | - CNY | -53.73% |
| 2021 Q4 | 0.03 CNY | -92.61% |
| 2021 Q1 | 0.14 CNY | -85.71% |
| 2021 FY | - CNY | -28.72% |
| 2021 Q2 | 0.65 CNY | 364.29% |
| 2021 Q3 | 0.36 CNY | -44.62% |
| 2020 Q2 | 0.39 CNY | 178.57% |
| 2020 Q1 | 0.14 CNY | -64.1% |
| 2020 Q3 | 0.22 CNY | -43.59% |
| 2020 Q4 | 0.98 CNY | 345.45% |
| 2020 FY | - CNY | 8.05% |
| 2019 Q4 | 0.39 CNY | 62.5% |
| 2019 FY | - CNY | 7.41% |
| 2019 Q3 | 0.24 CNY | -7.69% |
| 2019 Q2 | 0.26 CNY | 0.0% |
| 2019 Q1 | 0.26 CNY | 0.0% |
| 2018 FY | - CNY | -7.95% |
| 2017 FY | - CNY | 18.92% |
| 2016 FY | - CNY | 60.87% |
| 2015 FY | - CNY | -13.21% |
| 2014 FY | - CNY | -3.64% |
| 2013 FY | - CNY | 0.0% |